Post-earnings recap
Reported
Thu, May 1, 2025
EPS actual
$0.32
EPS est.
$0.33
EPS surprise
-3.32%
1-day move
-1.57%
Dexcom's earnings report showed a slight miss on EPS, which contributed to a 1.57% decline in stock price. The company did not provide revenue figures or future guidance, leaving investors uncertain about its growth trajectory. Management's cautious optimism suggests they are focused on maintaining demand and driving innovation, but the lack of specific guidance may weigh on investor sentiment.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.32 | N/A | -3.32% |
Management expressed cautious optimism about ongoing demand for their products. They highlighted their commitment to innovation as a key driver for future growth.
We are seeing steady demand for our products despite the challenges in the market.
Our focus remains on innovation and expanding our customer base.
Est. EPS
—
Est. Rev
—
Impl. Move
—